ZWZefeng Wang

Zefeng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zefeng Wang has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Yongquan Wu

    Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    6 shared publications
  • Liting Cheng

    Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    4 shared publications
  • Fei Hang

    Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    3 shared publications
  • Huanfu Liu

    Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    3 shared publications
  • Ziyu Wang

    Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    3 shared publications
  • Haiwei Li

    Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    2 shared publications

Latest Publications

  • Open Access

    Cardiac pacing in congenitally corrected transposition of the great arteries: technique, challenges, and outcome

    by Haiwei Li, Jieruo Chen, Fei Hang, Weiping Sun, Wenlong Dai, Yilun Tian, Hongkai Zhang, Liting Cheng, Huanfu Liu, Die Hu, et al.

  • Open Access

    Advances and challenges in personalized cardiac modeling and simulation for predicting the risk of sudden death from malignant arrhythmias in post-myocardial infarction

    by Erwei Zhao, Liting Cheng, Huanfu Liu, Zefeng Wang, Yongquan Wu

    Sudden cardiac death (SCD) represents a major global public health challenge, with malignant ventricular arrhythmias being its primary cause. This review focuses specifically on post-myocardial infarction (post-MI) ischemic cardiomyopathy—the most prevalent substrate for malignant ventricular arrhythmias. Current clinical practice predominantly relies on single functional indices, such as left ventricular ejection fraction, for risk stratification. This approach suffers from significant limitations in predictive accuracy, leading to dilemmas in the prophylactic application of implantable cardioverter-defibrillators, including both under-implantation and over-implantation. Personalized cardiac modeling and simulation technology, an advanced embodiment of the digital twin concept in cardiovascular medicine, offers a highly promising non-invasive solution to overcome these limitations. The core of this technology lies in the deep integration of personalized, multi-modal clinical imaging data, particularly late gadolinium enhancement sequences from cardiac magnetic resonance imaging. This enables the precise construction of individualized cardiac anatomical substrates that reflect the spatial distribution of myocardial fibrosis and scar. Building upon this anatomical foundation, multi-scale computational models are established, spanning from microscopic ion channel kinetics and cellular electrophysiological activity to macroscopic tissue conduction properties. These models systematically simulate core pro-arrhythmic factors under pathological conditions, including key ion channel remodeling, the coupling effects of non-myocytes, and alterations in anisotropic conduction properties of myocardial tissue. Ultimately, by implementing programmed electrical stimulation protocols on the computational heart model, the susceptibility to arrhythmias is dynamically assessed, achieving quantitative and visual stratification of an individual's SCD risk. This technological framework not only non-invasively reveals the dynamic electrical instability underlying static anatomical substrates but also demonstrates broad application prospects in understanding complex arrhythmia mechanisms, assisting in clinical therapeutic decision-making, and advancing the shift towards precision medicine models.

  • Open Access

    Clinical Utility of the 4S-AF Scheme in Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation

    by Naiyuan Cui, Haiwei Li, Weiping Sun, Zefeng Wang, Zhongyu Yuan, Botao Zhu, Yutong Liu, Huanfu Liu, Yongquan Wu, Xiaoping Zhang

    Background: The 4S-AF scheme, which comprises four domains related to atrial fibrillation (AF), stroke risk (St), symptom severity (Sy), severity of AF burden (Sb), and substrate (Su), represents a novel approach for structurally characterizing AF. This study aimed to assess the clinical utility of the scheme in predicting AF recurrence following radiofrequency catheter ablation (RFCA). Methods: We prospectively enrolled 345 consecutive patients with AF who underwent initial RFCA between January 2019 and December 2019. The 4S-AF scheme score was calculated and used to characterize AF. The primary outcome assessed was AF recurrence after RFCA, defined as any documented atrial tachyarrhythmia episode lasting at least 30 seconds. Results: In total, 345 patients (age 61 (interquartile range (IQR): 53–68) years, 34.2% female, 70.7% paroxysmal AF) were analyzed. The median duration of AF history was 12 (IQR: 3–36) months, and the median number of comorbidities was 2 (IQR: 1–3), and 157 (45.5%) patients had left atrial enlargement. During a median follow-up period of 28 (IQR: 13–37) months, AF recurrence occurred in 34.4% of patients. After eliminating the Sy and St domains, both the 4S-AF scheme (hazard ratio (HR) 1.38, 95% confidence interval (CI): 1.19–1.59, p < 0.001) and severity of burden and substrate of atrial fibrillation (2S-AF) scheme scores (HR 1.59, 95% CI: 1.33–1.89, p < 0.001) were independent predictors of AF recurrence following RFCA. For each domain, we found that the independent predictors were Sb (HR 1.84, 95% CI: 1.25–2.72, p = 0.002) and Su (HR 1.71, 95% CI: 1.36–2.14, p < 0.001). Furthermore, the 4S-AF (area under the curve (AUC) 65.2%, 95% CI: 59.3–71.1) and 2S-AF scheme score (AUC 66.2%, 95% CI: 60.2–72.1) had a modest ability to predict AF recurrence after RFCA. Conclusions: The novel 4S-AF scheme is feasible for evaluating and characterizing AF patients who undergo RFCA. A higher 4S-AF scheme score is independently associated with AF recurrence after RFCA. However, the ability of the 4S-AF scheme to discriminate between patients at high risk of recurrence was limited.


  • Open Access

    Anti-depressant medication use is a risk factor for incident knee surgery and opioid use in patients with knee osteoarthritis

    by Yongqiang Zheng, Jinshan Zhang, Zefeng Wang, Xiaofeng Liu, Yongquan Xu, Yangzhen Fang, Zhenyu Lin, Liang Lin

    Objective: To investigate whether depression and exposure to anti-depressant medication are independent risk factors for incident knee surgery and opioid use in knee osteoarthritis (KOA) patients.Methods: We identified all patients who visited our outpatient department and were clinically diagnosed with KOA between January 2010 and January 2018. We retrieved their demographic, clinical, and radiographic data from the database of our hospital. Next, we analyzed the effect of depression and anti-depressant medication on the incident knee surgery and opioid use in KOA patients.Results: A total of 4,341 KOA patients were found eligible to form the study population. Incident knee surgery and opioid use for the purpose of treating osteoarthritis were observed in 242 and 568 patients, respectively. Incident knee surgery was significantly associated with age (OR [95%CI], 1.024 [1.009–1.039], P = 0.002), BMI (OR [95%CI], 1.090 [1.054–1.128], P < 0.001), baseline K-L grade 3 (OR [95%CI], 1.977 [1.343–2.909], P = 0.001), baseline K-L grade 4 (OR [95%CI], 1.979 [1.241–3.157], P = 0.004), depression (OR [95%CI], 1.670 [1.088–2.563], P = 0.019), and exposure to anti-depressant medication (OR [95%CI], 2.004 [1.140–3.521], P = 0.016). Incident opioid use was significantly associated with depression (OR [95%CI], 1.554 [1.089–2.215], P = 0.015) and exposure to anti-depressant medication (OR [95%CI], 1.813 [1.110–2.960], P = 0.017).Conclusion: Depression and anti-depressant drug exposure were independently associated with incident knee surgery, highlighting the need for more attention on comorbid depression in KOA management.


  • Open Access

    Study on the Curative Effect and Safety of Radiofrequency Catheter Ablation of Paroxysmal Atrial Fibrillation via Zero-Fluoroscopy Transseptal Puncture under the Dual Guidance of Electroanatomical Mapping and Intracardiac Echocardiography

    by Fei Hang, Liting Cheng, Zhuo Liang, Ruiqing Dong, Xinlu Wang, Ziyu Wang, Zefeng Wang, Yongquan Wu

    Aims. 3D electroanatomical mapping combined with intracardiac echocardiography- (EAM-ICE-) guided transseptal puncture has been proven safe and effective during the radiofrequency catheter ablation (RFCA) procedure used to treat paroxysmal atrial fibrillation (PAF). In this study, we aimed to compare the curative effect and safety of RFCA via F (fluoroscopy) and zero-fluoroscopy transseptal puncture guided by EAM-ICE in patients with PAF. Methods and Results. A prospective study in which 110 patients with PAF were included and assigned to two groups was conducted. Fifty-five (50%) patients were enrolled in the EAM-ICE group, whereas the other 55 (50%) patients were enrolled in the F group. There were no significant differences in baseline characteristics between the two groups. The transseptal duration time was longer in the EAM-ICE group (19.8 ± 3.0 min vs. 8.6 ± 1.2 min, p ≤ 0.01 ); however, fluoroscopy was not used in the EAM-ICE group compared with the F group (0 mGy vs. 109.1 ± 57.9 mGy). Similarly, there was also no significant difference in the recurrence rate of atrial fibrillation between the EAM-ICE and F groups (25.5% vs. 18.2%, p = 0.356 ). Conclusion. RFCA via EAM-ICE-guided zero-fluoroscopy transseptal puncture in patients with PAF is safe and effective for long-term follow-up.


  • Open Access

    Zero‐fluoroscopy transseptal puncture guided by right atrial electroanatomical mapping combined with intracardiac echocardiography: A single‐center experience

    by Guangping Zhang, Liting Cheng, Zhuo Liang, Junmeng Zhang, Ruiqing Dong, Fei Hang, Xinlu Wang, Ziyu Wang, Lin Zhao, Zefeng Wang, et al.

    Background: Right atrial electroanatomical mapping may be combined with SoundStar 3D diagnostic ultrasound catheter (EAM‐ICE) as a zero‐fluoroscopy procedure for radiofrequency catheter ablation (RFCA). We aimed to evaluate the efficiency and safety of zero‐fluoroscopy transseptal puncture guided by EAM‐ICE and fluoroscopy combined with intracardiac echocardiography (F‐ICE) in patients with paroxysmal atrial fibrillation (PAF).Hypothesis: Zero‐fluoroscopy transseptal puncture is an effective and safe procedure.Methods: This study had a prospective design. A total of 57 patients with PAF were enrolled and assigned to two groups. Twenty‐seven patients were enrolled in the EAM‐ICE group, and 30 patients were enrolled in the F‐ICE group.Results: There were no statistically significant differences in baseline patient characteristics between groups. Transseptal puncture was successful in all patients (57/57, 100%). Total procedure time and duration of transseptal puncture were lower in the F‐ICE group (199.4 ± 26.0 minutes vs 150.7 ± 22.1 minutes, P = 0.000; 118.4 ± 19.7 vs 70.5 ± 13.5 minutes, P = 0.000). There was no use of fluoroscopy in the EAM‐ICE group (0 mGy vs 70.5 ± 13.5 mGy); the duration of fluoroscopy in the EAM‐ICE group was negligible (0 minutes vs 5.4 ± 1.9 minutes). No procedural complication occurred in either group.Conclusions: EAM‐ICE guided zero‐fluoroscopy transseptal puncture is an effective and safe procedure.


  • Open Access

    Swallowing‐induced atrial tachycardia associated with sympathetic activation: A case report

    by Xinlu Wang, Junmeng Zhang, Liting Cheng, Ziyu Wang, Zefeng Wang, Yongquan Wu

    A 51‐year‐old woman presented with a 5‐year history of a bypass tract of a left posterior septal ablation for atrioventricular reentrant tachycardia (AVRT). Following the procedure, while swallowing even without any water or food, she felt a new onset of palpitations, and swallowing‐induced atrial tachycardia was diagnosed. We report on this patient with tachycardia induced by swallowing who received a comprehensive assessment. The swallowing‐induced atrial tachycardia deriving from the right pulmonary vein was cured by catheter ablation. In our case, the swallowing‐induced atrial tachycardia was connected with the activation of the sympathetic nervous system, which differs from typical reports of a vagal nerve reflex association.